Organon & (US:OGN) Prnewswireยท2025-06-12 09:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to allegations of misleading statements and a significant reduction in quarterly dividends, which led to a sharp decline in the company's stock price [1][2]. Group 1: Allegations and Impact - The class period for the allegations is from October 31, 2024, to April 30, 2025 [2]. - Defendants allegedly provided overly positive statements while concealing material adverse facts about Organon's capital allocation priorities, particularly regarding debt reduction after the acquisition of Dermavant [2]. - Following the revelation of these issues, Organon's stock price plummeted from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, marking a decline of over 27% in just one day [2]. Group 2: Class Action Details - Shareholders are encouraged to register for the class action by the deadline of July 22, 2025, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, emphasizing the importance of responsible corporate behavior [4]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that artificially inflated stock prices [4].